Skip to Content

What type of drug is Verzenio?

Medically reviewed by N. France, BPharm. Last updated on Feb 4, 2021.

Official Answer

by Drugs.com

Verzenio (abemaciclib) is a small molecule drug and kinase inhibitor used to treat patients with advanced or metastatic (cancer that has spread) breast cancer. Verzenio is an ATP-competitive inhibitor of cyclin-dependent kinases 4 and 6 (CDK 4 and CDK6).

Verzenio is used:

  • In postmenopausal women taking an aromatase inhibitor as initial endocrine-based therapy for hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced for metastatic breast cancer.
  • In women taking fulvestrant (Faslodex) for HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression after endocrine therapy.
  • As a monotherapy in adult patients with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression after endocrine therapy and chemotherapy for metastatic disease.
References

Related Medical Questions

Drug Information

Related Support Groups